SEC
SlamSEC
Search
Browse
Earnings
AbbVie Inc. — SlamSEC
AbbVie Inc.
NYSE:
ABBV
Pharmaceutical Preparations
·
NORTH CHICAGO, IL
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Summary Financials
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois.
Revenue
$54.3B
-6.4% YoY
FY 2025
Adj. EBITDA
$13.5B
24.9% margin
FY 2025
Net Income
$4.9B
9.0% margin
FY 2025
EPS (Diluted)
$2.72
FY 2025
Stock Price
$227.45
-1.2%
2026-03-09
52W Range
$164.39 – $244.81
P/E Ratio
83.6x
Market Cap
$402.2B
Cash
$5.5B
FY 2025
Total Debt
$64.5B
FY 2025
Net Debt
$59.0B
FY 2025
Enterprise Value
$461.1B
Debt / EBITDA
4.4x
FY 2025
EV / EBITDA
34.1x
Employees
—